naringenin has been researched along with Cancer of Lung in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 5 (31.25) | 2.80 |
| Authors | Studies |
|---|---|
| Caro-Ramírez, JY; Ferrer, EG; Gonzalez, PJ; Naso, LG; Rivas, MG; Williams, PAM | 1 |
| Huang, XF; Jiao, X; Song, WX; Wang, K; Wu, P; Wu, WY; Xiao, PQ; Zhan, SF | 1 |
| Hu, C; Li, Q; Liu, X; Shi, Z; Sun, C; Zhao, T | 1 |
| Liang, W; Qin, Y; Wang, L; Wang, Z; Yin, X; Zeng, W; Zhang, C; Zhang, F | 1 |
| Cardoso, JC; Mendonça, MC; Morais, RP; Morsink, M; Novais, GB; Priefer, R; Sangenito, LS; Santos, ALS; Severino, P; Souto, EB | 1 |
| Arya, M; Guleria, A; Kanoujia, J; Kumar, A; Parashar, P; Saraf, SA; Singh, M; Tripathi, CB; Yadav, A | 1 |
| Birundha, K; Devi, KT; Kaveri, K; Kumar, SP | 1 |
| Hu, X; Li, C; Meng, S; Wu, Y; Zhang, H | 1 |
| Albuquerque, RM; Beraldo, H; de Azevedo, RA; Ferreira, AK; Gouvea, LR; Louro, SR; Sousa, AC; Tamayo, LV; Teixeira, SF | 1 |
| Barua, CC; Bodduluru, LN; Borah, P; Haloi, P; Hussain, MI; Kasala, ER; Madhana, RM | 1 |
| Dong, W; Liang, W; Qiu, Y; Wang, L; Yin, X; Zeng, W; Zhang, C; Zhang, F; Zhang, L | 1 |
| Du, G; Han, X; Jin, L; Liang, W; Song, Z; Zhang, H | 1 |
| Jin, L; Liang, W; Lu, L; Lu, X; Qin, L; Zhang, C; Zhang, F | 1 |
| Bak, Y; Hong, J; Jung, KY; Kang, JW; Kim, H; Kim, JH; Kim, MS; Lee, DH; Lim, Y; Park, YS; Yoon, DY | 1 |
| Aromaa, A; Hakulinen, T; Heliövaara, M; Järvinen, R; Knekt, P; Kumpulainen, J; Reunanen, A; Rissanen, H | 1 |
| Cho, SG; Choi, HY; Han, YS; Kang, GH; Kang, YJ; Kim, BW; Kim, JH; Lee, ER; Nah, SY; Paik, HD; Park, YS | 1 |
16 other study(ies) available for naringenin and Cancer of Lung
| Article | Year |
|---|---|
Copper(II) cation and bathophenanthroline coordination enhance therapeutic effects of naringenin against lung tumor cells.
Topics: Antineoplastic Agents; Antioxidants; Cations; Coordination Complexes; Copper; Flavanones; Glutathione Disulfide; Humans; Ligands; Lung Neoplasms; Phenanthrolines; Reactive Oxygen Species; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared | 2022 |
Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of
Topics: Antiviral Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; COVID-19; Humans; Lung Neoplasms; Molecular Docking Simulation; Network Pharmacology; Phosphatidylinositol 3-Kinases | 2023 |
Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells.
Topics: Antineoplastic Agents; Apigenin; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Lung Neoplasms | 2023 |
Naringenin Enhances the Antitumor Effect of Therapeutic Vaccines by Promoting Antigen Cross-Presentation.
Topics: Adenocarcinoma; Animals; Antigens, CD; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Citrus paradisi; Colonic Neoplasms; Cross-Priming; Dendritic Cells; Disease Models, Animal; Flavanones; Humans; Integrin alpha Chains; Lung Neoplasms; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Oxidative Stress; Papillomavirus E7 Proteins; Reactive Oxygen Species | 2020 |
Naringenin-Functionalized Multi-Walled Carbon Nanotubes: A Potential Approach for Site-Specific Remote-Controlled Anticancer Delivery for the Treatment of Lung Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Carriers; Drug Liberation; Flavanones; Humans; Lung Neoplasms; Nanotubes, Carbon; Tumor Cells, Cultured | 2020 |
Biotinylated naringenin intensified anticancer effect of gefitinib in urethane-induced lung cancer in rats: favourable modulation of apoptotic regulators and serum metabolomics.
Topics: A549 Cells; Animals; Apoptosis Regulatory Proteins; Drug Screening Assays, Antitumor; Female; Flavanones; Gefitinib; Humans; Lung Neoplasms; Male; Metabolomics; Neoplasm Proteins; Rats; Rats, Wistar; Urethane | 2018 |
Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Chitosan; Drug Compounding; Drug Liberation; Flavanones; Humans; Lung Neoplasms; Mice; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared | 2015 |
[Naringenin may block RSV-induced mucous hypersecretion in A549 cell via JNK/AP-1 signaling pathway].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Blotting, Western; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Flavanones; Humans; Lung Neoplasms; Mucin 5AC; Mucus; Random Allocation; Signal Transduction; Transcription Factor AP-1 | 2015 |
Copper(II) complexes with naringenin and hesperetin: cytotoxic activity against A 549 human lung adenocarcinoma cells and investigation on the mode of action.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Copper; DNA; Fibroblasts; Flavanones; Hesperidin; Human Umbilical Vein Endothelial Cells; Humans; Lung Neoplasms | 2016 |
Naringenin ameliorates inflammation and cell proliferation in benzo(a)pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NFκB and PCNA expression.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzopyrenes; Carcinogenesis; Cell Proliferation; Citrus; Cytochrome P-450 CYP1A1; Cytokines; Flavanones; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; NF-kappa B; Oxidation-Reduction; Proliferating Cell Nuclear Antigen; Tumor Cells, Cultured | 2016 |
Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Female; Flavanones; Humans; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Neoplasm Metastasis; Signal Transduction; Transforming Growth Factor beta1 | 2016 |
Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasis.
Topics: Animals; Bleomycin; Carcinoma, Lewis Lung; Cell Line, Tumor; Down-Regulation; Female; Flavanones; Forkhead Transcription Factors; Immunologic Factors; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pulmonary Fibrosis; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1 | 2009 |
Naringenin reduces lung metastasis in a breast cancer resection model.
Topics: Animals; Anticarcinogenic Agents; Antigens, CD; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemotherapy, Adjuvant; Female; Flavanones; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; T-Lymphocytes, Regulatory | 2011 |
A synthetic naringenin derivative, 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), induces apoptosis through up-regulation of Fas/FasL expression and inhibition of PI3K/Akt signaling pathways in non-small-cell lung cancer cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Fas Ligand Protein; fas Receptor; Flavanones; Humans; Hydrazones; Lung Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Up-Regulation | 2011 |
Flavonoid intake and risk of chronic diseases.
Topics: Adult; Arthritis, Rheumatoid; Asthma; Cataract; Cerebrovascular Disorders; Chronic Disease; Diabetes Mellitus, Type 2; Diet; Female; Flavanones; Flavonoids; Hesperidin; Humans; Kaempferols; Lung Neoplasms; Male; Middle Aged; Mortality; Myocardial Ischemia; Neoplasms; Prostatic Neoplasms; Quercetin; Risk; Risk Factors; Surveys and Questionnaires | 2002 |
Induction of apoptotic cell death by synthetic naringenin derivatives in human lung epithelial carcinoma A549 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma; Caspase 3; Cell Line, Tumor; Cell Survival; Flavanones; Fluorescent Dyes; Humans; Hydroxylation; Indoles; Lung Neoplasms; Reactive Oxygen Species | 2007 |